AB Sciex | GenomeWeb

AB Sciex

A report from Leerink predicted Thermo Fisher Scientific could launch such a system within the next year, potentially opening up the clinical mass spec market.

Researchers at Pacific Northwest National Laboratory are among those pushing ion mobility spectrometry as a tool to boost complex biological sample analysis.

Overall growth was driven by the company's diagnostics segment, which rose 11 percent, while life sciences improved 6 percent

The company has made significant progress implementing large-scale discovery workflows though challenges remain in terms of translation to the clinic.

The communication concerns a software defect that can cause several of the company's mass spectrometry instruments to incorrectly assign results to samples.

The Stoller Biomarker Discovery Centre, funded by the UK's Medical Research Council, recently opened to develop mass spec-based research for varied diseases.

The researchers found high reproducibility across quantitative proteomics workflows including SRM, PRM, and DIA performed on five different instruments.

While most firms launched new mass spec systems, the larger focus was on developing and implementing the larger workflows surrounding these instruments.

Funded by $10 million in seed money by the Australian Cancer Research Foundation, the center has purchased six Sciex TripleTOF 6600 mass spectrometers.

Under the agreement, PBI will promote its pressure cycling technology sample preparation systems with Sciex's mass spec instruments and Swath proteomics workflow.

Pages

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.